MALT1 Inhibition as a Therapeutic Strategy in T-Cell Acute Lymphoblastic Leukemia by Blocking Notch1-Induced NF-κB Activation

Current treatment of T-cell acute lymphoblastic leukemia (T-ALL) is primarily based on high-intensity combination chemotherapy, which has serious side effects. Therefore, developments of novel targeted therapeutics are urgently needed for treatment of T-ALL. In this study, we found that mucosa-assoc...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Rong Wang, Huihui Zhang, Jiawen Xu, Ninghan Zhang, Ting Pan, Xiaomin Zhong, Huanxin Zhang, Lingling Yin, Yao Yao, Qingyun Wu, Zhenyu Li, Xuejiao Liu, Kailin Xu, Mingshan Niu
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Frontiers Media S.A. 2020-09-01
Colecção:	Frontiers in Oncology
Assuntos:	T-ALL MALT1 MI-2 Notch1 NF-κB
Acesso em linha:	https://www.frontiersin.org/article/10.3389/fonc.2020.558339/full
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!